PRUDENTIAL FINANCIAL INC

Position in BEAM — Beam Therapeutics Inc.

CIK 1137774 NEWARK, NJ

Position in BEAM

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$561,475

+$205,813 QoQ

Shares Held

16,360

+9.6% QoQ

Ownership

0.016%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#135

of 274 holders

Holding Since

Dec 2020

11 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

PRUDENTIAL FINANCIAL INC holds $556,047,667 across 189 Biotechnology names. BEAM ranks #82 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	130,659	$81,471,112
2	VRTX	Vertex Pharmaceuticals Inc / Ma	133,294	$66,211,127
3	BMRN	Biomarin Pharmaceutical Inc	392,811	$22,476,644
4	INCY	Incyte Corp	191,312	$21,687,128
5	CYTK	Cytokinetics Inc	214,535	$18,276,236
6	LGND	Ligand Pharmaceuticals Inc	54,623	$17,265,784
7	PTCT	Ptc Therapeutics, Inc.	185,820	$15,157,337
8	MRVI	Maravai Lifesciences Holdings, Inc.	2,152,154	$13,429,440

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$561,475	16,360	+9.6%	Shares	Defined	2026-08-12
2026-03-31	$355,662	14,925	+25.5%	Shares	Defined	2026-05-13
2025-09-30	$288,570	11,890	+0.4%	Shares	Defined	2025-11-13
2025-06-30	$201,483	11,845	-15.9%	Shares	Defined	2025-08-12
2024-09-30	$345,180	14,089	+261.3%	Shares	Defined	2024-11-14
2022-03-31	$223,470	3,900	+0.6%	Shares	Defined	2022-05-13
2021-12-31	$308,798	3,875	-7.7%	Shares	Defined	2022-02-14
2021-09-30	$365,442	4,200	+12.8%	Shares	Defined	2021-11-15
2021-06-30	$479,444	3,725	+12.7%	Shares	Defined	2021-08-16
2021-03-31	$264,532	3,305	+10.0%	Shares	Defined	2021-05-12
2020-12-31	$245,328	3,005	—	Shares	Defined	2021-08-16
No filing history on record for this holder in this stock.